1. Home
  2. RGEN vs GTLS Comparison

RGEN vs GTLS Comparison

Compare RGEN & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • GTLS
  • Stock Information
  • Founded
  • RGEN 1981
  • GTLS 1859
  • Country
  • RGEN United States
  • GTLS United States
  • Employees
  • RGEN N/A
  • GTLS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • GTLS Metal Fabrications
  • Sector
  • RGEN Health Care
  • GTLS Industrials
  • Exchange
  • RGEN Nasdaq
  • GTLS Nasdaq
  • Market Cap
  • RGEN 8.0B
  • GTLS 9.2B
  • IPO Year
  • RGEN N/A
  • GTLS 1992
  • Fundamental
  • Price
  • RGEN $118.07
  • GTLS $156.83
  • Analyst Decision
  • RGEN Buy
  • GTLS Strong Buy
  • Analyst Count
  • RGEN 12
  • GTLS 10
  • Target Price
  • RGEN $172.67
  • GTLS $198.80
  • AVG Volume (30 Days)
  • RGEN 791.0K
  • GTLS 484.0K
  • Earning Date
  • RGEN 04-29-2025
  • GTLS 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • GTLS N/A
  • EPS Growth
  • RGEN N/A
  • GTLS 416.59
  • EPS
  • RGEN N/A
  • GTLS 4.96
  • Revenue
  • RGEN $650,429,000.00
  • GTLS $4,211,100,000.00
  • Revenue This Year
  • RGEN $13.93
  • GTLS $14.25
  • Revenue Next Year
  • RGEN $14.35
  • GTLS $9.93
  • P/E Ratio
  • RGEN N/A
  • GTLS $31.19
  • Revenue Growth
  • RGEN 4.88
  • GTLS 11.65
  • 52 Week Low
  • RGEN $102.97
  • GTLS $101.60
  • 52 Week High
  • RGEN $182.52
  • GTLS $220.03
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.80
  • GTLS 50.30
  • Support Level
  • RGEN $120.55
  • GTLS $151.92
  • Resistance Level
  • RGEN $123.71
  • GTLS $163.56
  • Average True Range (ATR)
  • RGEN 4.63
  • GTLS 4.96
  • MACD
  • RGEN -0.58
  • GTLS -1.62
  • Stochastic Oscillator
  • RGEN 7.59
  • GTLS 19.10

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About GTLS Chart Industries Inc.

Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company.

Share on Social Networks: